CRBN 📈 Corbion - Overview
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0010583399
CRBN: Lactic Acid, Derivatives, Enzymes, Minerals, Vitamins, Algae Ingredients
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was incorporated in 1919 and is headquartered in Amsterdam, the Netherlands. Web URL: https://www.corbion.com
Additional Sources for CRBN Stock
CRBN Stock Overview
| Market Cap in USD | 1,341m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
CRBN Stock Ratings
| Growth 5y | -18.4% |
| Fundamental | 67.7% |
| Dividend | 43.8% |
| Rel. Strength Industry | 11476 |
| Analysts | - |
| Fair Price Momentum | 20.72 EUR |
| Fair Price DCF | 9.22 EUR |
CRBN Dividends
| Dividend Yield 12m | 3.30% |
| Yield on Cost 5y | 2.74% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 92.0% |
CRBN Growth Ratios
| Growth Correlation 3m | -86.6% |
| Growth Correlation 12m | 87.5% |
| Growth Correlation 5y | -68.3% |
| CAGR 5y | -3.71% |
| CAGR/Mean DD 5y | -0.11 |
| Sharpe Ratio 12m | 0.39 |
| Alpha | -5.56 |
| Beta | 0.64 |
| Volatility | 29.34% |
| Current Volume | 132.3k |
| Average Volume 20d | 68.7k |
What is the price of CRBN stocks?
As of December 21, 2024, the stock is trading at EUR 21.38 with a total of 132,328 shares traded.
Over the past week, the price has changed by -3.84%, over one month by -1.91%, over three months by -9.66% and over the past year by +17.47%.
As of December 21, 2024, the stock is trading at EUR 21.38 with a total of 132,328 shares traded.
Over the past week, the price has changed by -3.84%, over one month by -1.91%, over three months by -9.66% and over the past year by +17.47%.
Is Corbion a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Corbion (AS:CRBN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.72 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRBN as of December 2024 is 20.72. This means that CRBN is currently overvalued and has a potential downside of -3.09%.
Yes, based on ValueRay Fundamental Analyses, Corbion (AS:CRBN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.72 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRBN as of December 2024 is 20.72. This means that CRBN is currently overvalued and has a potential downside of -3.09%.
Is CRBN a buy, sell or hold?
Corbion has no consensus analysts rating.
Corbion has no consensus analysts rating.
What are the forecast for CRBN stock price target?
According to ValueRays Forecast Model, CRBN Corbion will be worth about 22.5 in December 2025. The stock is currently trading at 21.38. This means that the stock has a potential upside of +5.05%.
According to ValueRays Forecast Model, CRBN Corbion will be worth about 22.5 in December 2025. The stock is currently trading at 21.38. This means that the stock has a potential upside of +5.05%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 26 | 21.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.5 | 5.1% |